Bioxytran, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BIXT | CVKD | BLRX | XBIO | ET80.F | BIVI | |
|---|---|---|---|---|---|---|
| Market cap | 2.42M | 3.78M | 9.26M | 4.71M | 5.30M | 11.63M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | -0.3 | -0.7 | -3.0 | — | -2.4 |
| Price/book | -0.5 | 0.8 | 0.6 | 0.8 | 0.4 | 1.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −69.99% | −91.31% | −44.14% | −26.10% | −16.51% | −10.67% |
| Today | −2.76% | −6.19% | −2.62% | −3.37% | +0.95% | −22.54% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All BIXT news ›Bioxytran Leverages Artificial Super Intelligence (ASI) to Design Broad-Spectrum Antiviral and Anti-Cancer Metastasis Drugs
What Is Artificial Super Intelligence (ASI)? How ASI Powers Antiviral Drug Design? How ASI Enables Anti-Cancer Metastasis Drug Development? All three of Bioxytran's platform technologies—broad-spectrum oral antivirals, cancer metastasis…
Bioxytran Highlights New Book on Real-Time Monitoring Tissue Oxygenation Relevant to Oxygen Carrier BXT-25
Brain tissue oxygenation in early stage of stroke with BXT-25 is monitored in real time The book also explores metabolic oscillations observed in ischemic brain tissue and examines the role of nitric oxide in ischemia, hypoxia,…
Bioxytran Completes Production of Two Dietary Supplements: V-LO® for Immune Health and A-SUQAR® for Healthy Blood Sugar
Finished inventory of both products has been manufactured; Company is finalizing go-to-market plans V-LO®: Immune Health Support V-LO® is a dietary supplement designed to support normal immune function. It is a 2-gr. polysaccharide…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- markets.businessinsider.com2
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.